Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	807-807
Journal	Current pharmaceutical design
Volume	19
Issue number	5
DOIs	https://doi.org/10.2174/138161213804547231
Publication status	Published - 2013

Access to Document

@article{fc4ac240a40442e2b3b3c174d9eaf003,

title = "Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer",

author = "E. Giovannetti and G.J. Peters",

year = "2013",

doi = "https://doi.org/10.2174/138161213804547231",

language = "Undefined/Unknown",

volume = "19",

pages = "807--807",

journal = "Current pharmaceutical design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "5",

}

TY - JOUR

T1 - Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer

AU - Giovannetti, E.

AU - Peters, G.J.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.2174/138161213804547231

DO - https://doi.org/10.2174/138161213804547231

M3 - Article

SN - 1381-6128

VL - 19

SP - 807

EP - 807

JO - Current pharmaceutical design

JF - Current pharmaceutical design

IS - 5

ER -